A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC)

NCT05068141 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: SG001
DRUG: Nab-paclitaxel

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.